The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

点击蓝字关注我们【导读】癌症疫苗面临的一个基本挑战，是如何产生对肿瘤抗原具有特异性的长效功能性T细胞。在这项研究中，团队发现针对体细胞突变衍生的新抗原的mRNA脂质体疫苗，可以解决胰腺导管腺癌（PDAC）的这一难题。2025年2月19日，美国纪念斯隆 ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Colorectal cancer and pancreatic ductal adenocarcinoma that harbored the KRAS G12C mutation often carried other genetic alterations that can be associated with resistance to KRAS G12C inhibitors, ...

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based ...